These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 19105413)

  • 1. [Metabolic syndrome and chronic disease of the kidneys: the role of age-related androgenic deficiency. New approaches to treatment (review)].
    Novikova MS; Kalinchenko SIu; Borisov VV
    Ter Arkh; 2008; 80(10):41-6. PubMed ID: 19105413
    [No Abstract]   [Full Text] [Related]  

  • 2. Testosterone therapy improves the clinical response to conventional treatment for male patients with metabolic syndrome associated to late onset hypogonadism.
    La Vignera S; Calogero AE; D'Agata R; Di Mauro M; Tumino S; Condorelli R; Lanzafame F; Finocchiaro C; Giammusso B; Vicari E
    Minerva Endocrinol; 2008 Sep; 33(3):159-67. PubMed ID: 18846023
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Treatment of lipid disorders in metabolic syndrome and type 2 diabetes. The place for fibrates].
    Cybulska B; Kłosiewicz-Latoszek L
    Kardiol Pol; 2005 Jun; 62 Suppl 2():II45-50. PubMed ID: 19813336
    [No Abstract]   [Full Text] [Related]  

  • 4. Obesity and cardiometabolic syndrome in children.
    Velasquez-Mieyer P; Neira CP; Nieto R; Cowan PA
    Ther Adv Cardiovasc Dis; 2007 Oct; 1(1):61-81. PubMed ID: 19124396
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Solvay addresses unmet needs in the management of hypertensive patients with cardiometabolic and lipid disorders.
    Cardiovasc J Afr; 2009; 20(1):73-4. PubMed ID: 19287821
    [No Abstract]   [Full Text] [Related]  

  • 6. The metabolic syndrome as an endocrine disease: is there an effective pharmacotherapeutic strategy optimally targeting the pathogenesis?
    Schindler C
    Ther Adv Cardiovasc Dis; 2007 Oct; 1(1):7-26. PubMed ID: 19124392
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The current unmet need in type 2 diabetes mellitus: addressing glycemia and cardiovascular disease.
    Levy P
    Postgrad Med; 2009 May; 121(3 Suppl 1):7-12. PubMed ID: 19494472
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vascular disease in the metabolic syndrome: do we need to target the microcirculation to treat large vessel disease?
    Krentz AJ; Clough G; Byrne CD
    J Vasc Res; 2009; 46(6):515-26. PubMed ID: 19571572
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 4-Hydroxyisoleucine: a plant-derived treatment for metabolic syndrome.
    Jetté L; Harvey L; Eugeni K; Levens N
    Curr Opin Investig Drugs; 2009 Apr; 10(4):353-8. PubMed ID: 19337956
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The metabolic syndrome: a gathering challenge in a time of abundance.
    Bricker LA; Greydanus DE
    Adolesc Med State Art Rev; 2008 Dec; 19(3):475-97, ix. PubMed ID: 19227387
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lipid management in children.
    Zappalla FR; Gidding SS
    Endocrinol Metab Clin North Am; 2009 Mar; 38(1):171-83. PubMed ID: 19217518
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Heart and kidneys].
    Rutkowski B; Rutkowski P
    Przegl Lek; 2005; 62 Suppl 2():3-6. PubMed ID: 16623108
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence of metabolic syndrome in the Mediterranean region of Turkey: evaluation of hypertension, diabetes mellitus, obesity, and dyslipidemia.
    Gündogan K; Bayram F; Capak M; Tanriverdi F; Karaman A; Ozturk A; Altunbas H; Gökce C; Kalkan A; Yazici C
    Metab Syndr Relat Disord; 2009 Oct; 7(5):427-34. PubMed ID: 19754305
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hypertension and the cardiometabolic syndrome in Chile: a review of concepts and consequences for the developing world.
    Margozzini P; Rigotti A; Ferreccio C; Quezada N; Garrido M; Valdés G
    Ther Adv Cardiovasc Dis; 2007 Oct; 1(1):83-90. PubMed ID: 19124397
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Insulin resistance and nitric oxide and associated renal injury: innocent bystanders or accessories to the crime?
    Ahmed MH
    N Z Med J; 2006 Aug; 119(1239):U2112. PubMed ID: 16912729
    [No Abstract]   [Full Text] [Related]  

  • 16. On the road to better dyslipidemia outcomes.
    Hughes S
    Nurse Pract; 2009 Feb; 34(2):14-21; quiz 22. PubMed ID: 19155874
    [No Abstract]   [Full Text] [Related]  

  • 17. Metabolic syndrome in rheumatological diseases.
    Pereira RM; de Carvalho JF; Bonfá E
    Autoimmun Rev; 2009 Mar; 8(5):415-9. PubMed ID: 19168158
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of hypertension, diabetes, dyslipidemia, and metabolic syndrome with obesity: findings from the National Health and Nutrition Examination Survey, 1999 to 2004.
    Nguyen NT; Magno CP; Lane KT; Hinojosa MW; Lane JS
    J Am Coll Surg; 2008 Dec; 207(6):928-34. PubMed ID: 19183541
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metabolic syndrome in pediatrics: old concepts revised, new concepts discussed.
    D'Adamo E; Santoro N; Caprio S
    Endocrinol Metab Clin North Am; 2009 Sep; 38(3):549-63. PubMed ID: 19717004
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of tumor necrosis factor-alpha blockade on metabolic syndrome components in psoriasis and psoriatic arthritis and additional lessons learned from rheumatoid arthritis.
    Channual J; Wu JJ; Dann FJ
    Dermatol Ther; 2009; 22(1):61-73. PubMed ID: 19222518
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.